-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Insider Buying: Eterna Therapeutics Inc. (NASDAQ:ERNA) Major Shareholder Buys $1,101,817.60 in Stock
Insider Buying: Eterna Therapeutics Inc. (NASDAQ:ERNA) Major Shareholder Buys $1,101,817.60 in Stock
Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Rating) major shareholder John D. Halpern acquired 335,920 shares of the stock in a transaction on Friday, December 2nd. The stock was acquired at an average cost of $3.28 per share, for a total transaction of $1,101,817.60. Following the acquisition, the insider now directly owns 450,961 shares in the company, valued at approximately $1,479,152.08. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Eterna Therapeutics Trading Up 4.7 %
Shares of NASDAQ:ERNA opened at $4.67 on Thursday. Eterna Therapeutics Inc. has a 12 month low of $2.73 and a 12 month high of $127.60.
Get Eterna Therapeutics alerts:About Eterna Therapeutics
(Get Rating)
Brooklyn ImmunoTherapeutics, Inc, a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease.Recommended Stories
- Get a free copy of the StockNews.com research report on Eterna Therapeutics (ERNA)
- Are Investors Hearing The End Of Spotify's Downtrend?
- The Question of a Fed Pivot Isn't If, It's When, Here's Why
- Top 10 Searched Stocks on MarketBeat All-Access
- 3 Dividend Kings With Royally Good Upside
- Institutions Sell The Rallies In Toll Brothers Stock
Receive News & Ratings for Eterna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eterna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Rating) major shareholder John D. Halpern acquired 335,920 shares of the stock in a transaction on Friday, December 2nd. The stock was acquired at an average cost of $3.28 per share, for a total transaction of $1,101,817.60. Following the acquisition, the insider now directly owns 450,961 shares in the company, valued at approximately $1,479,152.08. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Eterna Therapeutics Inc.(纳斯达克股票代码:ERNA — Get Rating)主要股东约翰·哈尔珀恩在12月2日星期五的一笔交易中收购了该股335,920股。该股的平均收购成本为每股3.28美元,总交易额为1,101,817.60美元。收购后,该内部人士现在直接拥有该公司的450,961股股份,价值约为1,479,152.08美元。此次收购是在向美国证券交易委员会提交的一份文件中披露的,该文件可通过以下方式获取 美国证券交易委员会网站。拥有公司至少 10% 股份的主要股东必须向美国证券交易委员会披露其销售和购买情况。
Eterna Therapeutics Trading Up 4.7 %
Eterna Therapeutics 交易价格上涨
Shares of NASDAQ:ERNA opened at $4.67 on Thursday. Eterna Therapeutics Inc. has a 12 month low of $2.73 and a 12 month high of $127.60.
纳斯达克股票代码:ERNA的股价周四开盘价为4.67美元。Eterna Therapeutics Inc.创下12个月低点2.73美元,12个月高点为127.60美元。
About Eterna Therapeutics
关于埃特纳疗法
(Get Rating)
(获取评分)
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Eterna Therapeutics (ERNA)
- Are Investors Hearing The End Of Spotify's Downtrend?
- The Question of a Fed Pivot Isn't If, It's When, Here's Why
- Top 10 Searched Stocks on MarketBeat All-Access
- 3 Dividend Kings With Royally Good Upside
- Institutions Sell The Rallies In Toll Brothers Stock
- 免费获取 StockNews.com 关于 Eterna Therapeutics (ERNA) 的研究报告
- 投资者在听见 Spotify 下跌趋势的结束吗?
- 美联储转向的问题不在于是否,而是何时,这就是原因
- MarketBeat All-Access 上搜索
- 3 位股息之王,上行空间不错
- 机构卖出 Toll Brothers 股票的涨势
Receive News & Ratings for Eterna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eterna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Eterna Therapeutics 每日的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Eterna Therapeutics及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧